Study seeks best treatment order for kidney cancer patients
NCT ID NCT07324876
Summary
This study aims to find out which order of treatments works better for Chinese patients with advanced kidney cancer after their first treatment stops working. Researchers will compare two approaches: starting with drug therapy alone followed by drug plus immunotherapy, versus starting with the combination and then switching to drug therapy alone. The goal is to identify which sequence helps patients live longer with better quality of life while managing treatment costs.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RCC are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Tianjin Medical University Cancer Institute and Hospital
Tianjin, China
Conditions
Explore the condition pages connected to this study.